Greggs has overtaken Nvidia as the most searched-for stock in the UK. According to Google Trends these stocks are breaking out with massive search interest which could suggest people are interested in buying them. We take a look at what shares UK investors are searching for information on and give our forecasts.
Deepseek
The Chinese AI isnβt listed even in China, but itβs doubtful that a startup, albeit one that is backed by a large hedge fund, has ever made such a dramatic appearance on the world stage.
Itβs unlikely that all the claims about the development of the resource light artificial intelligence are genuine. However, what canβt be denied is that it can be deployed using far less computing power than its western rivals and thatβs shaken the prevailing AI/data centre investment thesis to its roots. That has dramatically affected share prices of the Magnificent 7, chip makers and infrastructure providers around the globe.
Sealand Capital Galaxy
Sealand Capital Galaxy is an SPV or special purpose vehicle that engages in digital marketing and ecommerce related activities in Asia. Itβs a relative minnow with a market cap of just over Β£58.0 million. However, itβs punching above its weight in terms of investor interest with its share price having risen by more than +116.0% in the last month following the appointment of Thomas Sawyer as its new chief executive officer.
That said the stock price peaked back on Jan 20th at 11.90p and itβs been downhill ever since. The stock is tightly held with almost 60.0% in the hands of βinsidersβ Mr Sawyer has been granted share options at 12p so he is incentivised to get the shares above that price over the next 12 months.
ImmuPharma PLC
Is a drug development business with a pipeline that includes peptide-based treatments in the areas of autoimmunity & inflammation, including Lupuzor, which treats the life threatening disease Lupus.
The stock price has risen by +334.0% in the last month including a single daily gain of 94.0%. The rally came about after ImmuPharma announced positive pre clinical trial results for its P140 autoimmune treatment.
But such has been the reaction in the share price,that the company was forced to make a statement to the effect that it knew of no other news that should affect the share price. Biotech & pharmaceutical research stocks can be notoriously volatile as share prices swing on sentiment, until successful treatments/drug discoveries come to fruition. as such investors should exercise a degree of caution.
Greggs Plc
The UKs best known bakery chain is famous for its sausage rolls and steak slices, however the company’s shares have not proved as popular over the last month. Having fallen by more than -24.0% in that time.
HSBC upgraded the stock to buy back Jan 24th with a Β£25.00 price target.
However Greggs is one of the companies that could be most affected by the changes announced in the autumn budget, incurring a triple whammy of higher minimum wages, employers NI contributions and business rates. Shareholders will find out more about current trading and the outlook for the business with the publication of its final results in early March.
Nvidia Inc
Nvidia is one of the companies that could be most affected by the emergence of DeepSeek, based on the premise that the Chinese AI was trained on previous generations of GPUs rather than the latest generation of Nvidia silicon.
Nvidia doesnβt make or operate AIs itself, rather it sells the picks and shovels to the AI βminersβ (mega cap technology firms) who have been queuing up to spend billions on the latest kit. The idea that you could achieve similar results using equipment thatβs far cheaper, and freely ,using far less power and other resources was a body blow to what had become a seemingly invincible business and one of the worldβs largest companies.
The shares have fallen by more than -21.0% over the last month as investors try to reconcile themselves to this new world order. Some of DeepSeeks developerβs claims seem to have been debunked, but there is no doubt that ground has shifted irrevocably under our feet. Nvidia will report earnings after the close on February 26th.

With over 35 years of finance experience, Darren is a highly respected and knowledgeable industry expert. With an extensive career covering trading, sales, analytics and research, he has a vast knowledge covering every aspect of the financial markets.
During his career, Darren has acted for and advised major hedge funds and investment banks such as GLG, Thames River, Ruby Capital and CQS, Dresdner Kleinwort and HSBC.
In addition to the financial analysis and commentary he provides as an editor at GoodMoneyGuide.com, his work has been featured in publications including Fool.co.uk.
As well as extensive experience of writing financial commentary, he previously worked as a Market Research & Client Relationships Manager at Admiral Markets UK Ltd, before providing expert insights as a market analyst at Pepperstone.
Darren is an expert in areas like currency, CFDs, equities and derivatives and has authored over 260 guides on GoodMoneyGuide.com.
He has an aptitude for explaining trading concepts in a way that newcomers can understand, such as this guide to day trading Forex at Pepperstone.com
Darren has done interviews and analysis for companies like Queso, including an interview on technical trading levels.
A well known authority in the industry, he has provided interviews on Bloomberg (UK), CNBC (UK) Reuters (UK), Tiptv (UK), BNN (Canada) and Asharq Bloomberg Arabia.
You can contact Darren at darrensinden@goodmoneyguide.com